4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-068650
Chief Business Officer sold 7,593 shares at an average $26.88 ($204,063)
- Chief Business Officer gave up 8,788 shares (to pay taxes)
- Chief Business Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2023-12-04 | Option exercise | +15,000 | $3.29 | $49,350 | 37,771 | D |
| Robb Gary Charles Chief Business Officer | 2023-12-04 | Shares withheld for taxes | −8,788 | $26.26 | $230,773 | 28,983 | D |
| Robb Gary Charles Chief Business Officer | 2023-12-05 | Sale | −1,381 | $26.27 | $36,277 | 27,602 | D |
| Robb Gary Charles Chief Business Officer | 2023-12-06 | Sale | −6,212 | $27.01 | $167,786 | 21,390 | D |
| Derivatives | |||||||
| Robb Gary Charles Chief Business Officer | 2023-12-04 | Option exercise · Stock option (right to buy) | −15,000 | 61,037 | D | ||
| Open-market sales · 7,593 sh · avg $26.88 · $204,063 | |||||||
Loading xslF345X05/ownership.xml…